A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.
about
A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@en
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@nl
type
label
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@en
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@nl
prefLabel
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@en
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@nl
P2093
P2860
P50
P921
P356
P1476
A Randomized Switch From Nevir ...... ncy Virus-1-Infected Rwandans.
@en
P2093
Adeline Mugeni
Andrew Zolopa
Annie Talbot
Deborah Slamowitz
Eric Remera
Eric Seruyange
Francois Uwinkindi
Jean Paul Uwizihiwe
Jean-Baptiste Mazarati
Josbert Nyirimigabo
P2860
P304
P356
10.1093/OFID/OFW141
P577
2016-07-01T00:00:00Z